Table 1 Clinical and imaging characteristics
From: Evaluating effects of normobaric oxygen therapy in acute stroke with MRI-based predictive models
| Â | Control-treated (n = 6) | NBO-treated (n = 10) |
|---|---|---|
|  | Mean ± SD (Median) | Mean ± SD (Median) |
Age (y) | 71 ± 18 (71) | 67 ± 16 (70) |
Female | 4 (67%) | 5 (50%) |
Time Intervals | Â | Â |
Symptom onset to admission MRI (h) | 4.4 ± 2.0 (4.4) | 7.3 ± 4.5 (5.9) |
Admission-to-treatment MRI (h) | 5.0 ± 1.4 (4.8) | 4.3 ± 1.5 (3.9) |
Admission-to-post-treatment MRI (h) | 24.8 ± 1.9 (24.8) | 24.4 ± 1.5 (24.2) |
Admission-to-discharge MRI (d) | 6.7 ± 1.9 (6.6) | 6.0 ± 1.4 (5.8) |
Acute NIHSSS | 11 (9-12) | 14 (9-18) |
Reperfusion | Â | Â |
Admission-to-treatment | 1 (17%) | 0 |
Treatment to post-treatment | 0 | 5 (50%) |
Measured Lesion Volume (cm 3 ) | Â | Â |
Admission DWI | 27 ± 44 (8) cm3 | 37 ± 24 (30) cm3 |
4 h DWI | 28 ± 34 (15) cm3 | 35 ± 25 (27) cm3 |
24 h DWI | 32 ± 39 (15) cm3 | 49 ± 37 (43) cm3 |
Discharge | 41 ± 48 (23) cm3 | 66 ± 42 (53) cm3 |
Lesion Change (%) | Â | Â |
4h* | 153 ± 96 (134)% | 90 ± 22 (90)% |
24h | 186 ± 142 (148)% | 129 ± 29 (134)% |
Discharge | 223 ± 91 (203)% | 192 ± 81 (178)% |